KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $501.6 million.

  • Charles River Laboratories International's Free Cash Flow fell 16.34% to $178.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $543.7 million, marking a year-over-year decrease of 3.00%. This contributed to the annual value of $501.6 million for FY2024, which is 37.29% up from last year.
  • According to the latest figures from FY2024, Charles River Laboratories International's Free Cash Flow is $501.6 million, which was up 37.29% from $365.4 million recorded in FY2023.
  • Charles River Laboratories International's 5-year Free Cash Flow high stood at $532.0 million for FY2021, and its period low was $294.9 million during FY2022.
  • In the last 3 years, Charles River Laboratories International's Free Cash Flow had a median value of $365.4 million in 2023 and averaged $387.3 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first surged by 40.00% in 2021, then tumbled by 44.57% in 2022.
  • Over the past 5 years, Charles River Laboratories International's Free Cash Flow (Yearly) stood at $380.0 million in 2020, then soared by 40.00% to $532.0 million in 2021, then crashed by 44.57% to $294.9 million in 2022, then increased by 23.89% to $365.4 million in 2023, then soared by 37.29% to $501.6 million in 2024.